Abstract |
This study aimed to determine how antibiotic-driven intestinal dysbiosis impairs the development and differentiation of the digestive tract and immune organs of host animals. BALB/C neonatal mice were orally administered ceftriaxone or vancomycin from postnatal day 1 to day 21 and sacrificed on day 21. The diversity and abundance of the intestinal bacteria, morphological changes and barrier function of intestinal tract, and the splenic CD4+CD25+Foxp3+ T cells were investigated. The gut microbiota and intestinal tissue were damaged, and the numbers of Ki67-, Muc2- and ZO-1-positive cells were significantly decreased in the antibiotic treatment groups. Furthermore, the administration of ceftriaxone, but not vancomycin, led to a significant reduction in the abundance of splenic CD4+CD25+Foxp3+ T cells. Each antibiotic caused intestinal dysbiosis and characteristically influenced the regeneration of intestinal epithelial cells, formation of the intestinal mucus layer and tight junctions, and differentiation of splenic Foxp3+ Treg cells of the neonatal mice before any clinical side effects were observed. The potent ability of each antibiotic to affect the makeup of intestinal commensal microbiota may be a key determinant of the spectrum of antibiotics and influence the health of the host animal, at least partly.
|
Authors | Ru Yue Cheng, Ming Li, Shan Shan Li, Miao He, Xiao Hong Yu, Lei Shi, Fang He |
Journal | Pathogens and disease
(Pathog Dis)
Vol. 75
Issue 8
(11 30 2017)
ISSN: 2049-632X [Electronic] United States |
PMID | 28957452
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © FEMS 2017. All rights reserved. For permissions, please e-mail: [email protected]. |
Chemical References |
- Anti-Bacterial Agents
- Vancomycin
- Ceftriaxone
|
Topics |
- Animals
- Animals, Newborn
- Anti-Bacterial Agents
(toxicity)
- Ceftriaxone
(toxicity)
- Gastrointestinal Microbiome
(drug effects)
- Gastrointestinal Tract
(drug effects)
- Immune System
(drug effects)
- Mice
- Mice, Inbred BALB C
- Random Allocation
- Vancomycin
(toxicity)
|